Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 599-602

Spandidos Publications

Access to resources Recommend Favorite

Anti-Angiogenic Cancer Therapy Based on Integrin v&bgr;3 Antagonism

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 407-428

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Therapy of Breast Cancer with a Radioiodinated Humanized Anti-EGP-1 Monoclonal Antibody: Advantage of a Residualizing Iodine Radiolabel

By Govindan Serengulam V.   Stein Rhona   Qu Zhengxing   Chen Susan   Andrews Philip   Ma Hong   Hansen Hans J.   Griffiths Gary L.   Horak Ivan D.   Goldenberg David M.  

Breast Cancer Research and Treatment, Vol. 84, Iss. 2, 2004-03 ,pp. : 173-182

Springer Publishing Company

Access to resources Recommend Favorite

Insights into the Role of Fc Gamma Receptors (Fc&ggr;Rs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite